ORIGINAL STUDIES |
Ladnov D.V., Kulik V.V., Kirpichnikov S.I., Shaporova N.L.
Mild forms of COVID-19: the clinical course features in patients with chronic obstructive pulmonary disease
|
7-13 |
Antonov V.N., Osikov M.V., Ignatova G.L., Zotov S.O.
Heparin type influence on cellular hemostasis indicators in COVID-19-associated pneumonia
|
14-21 |
Baranov D.Z., Trofimov V.I., Lapin S.V., Mazing A.V., Kholopova I.V., Kuznetsova D.A., Moshnikova A.N., Blinova T.V.
Evaluation of periostin in case of bronchoostructive diseases
|
22-29 |
Sorokina L.N., Pavlova A.S., Mineev V.N., Trofimov V.I.
Chronic obstructive pulmonary disease in combination with type 2 diabetes mellitus: features of the clinical picture
|
30-37 |
Ignatova I.V., Blinova E.V., Antonov V.N.
Analysis of factors of poor outcome in patients with COPD and type 2 diabetes mellitus: results of a 10-year follow-up
|
38-45 |
Shuginova T.N., Meldo A.A., Shaporova N.L., Moiseenko F.V., Klikunova K.A.
Pulmonary function test for chronic obstructive pulmonary disease patients with non-small cell lung cancer
|
46-53 |
Vysotskaya N.V., Li V.V., Zadionchenko V.S., Adasheva T.V., Dolbin S.S., Timofeeva N.Yu.
Vascular wall rigidity in chronic obstructive pulmonary disease patients
|
54-64 |
Kucherenko N.G., Bebekh A.N., Umarova I.A., Gorelov A.I.
Dyspnoea and respiratory mechanics disturbances in obesity patients
|
65-69 |
Kobzeva N.D.
Features of the influence of atherosclerotic damage of various vascular basins on the risk of development of fatal and non-fatal events in a long period
|
70-75 |
Umetov M.A., Khakuasheva I.A., Akkaeva M.R., Tamazova M.A., Sanova A.Z., Khakulova D.M.
Influence of complex drug therapy on structural and functional properties of vessels and endothelial dysfunction in patients with arterial hypertension and ischemic heart disease
|
76-83 |
Heylo T.S., Danilogorskaya Yu.A., Nazarenko G.B., Gladysheva E.G.
Dynamics of microcirculation indices in patients with chronic ischemic diseases of the central nervous and cardiovascular systems
|
84-92 |
Shchemeleva E.V., Skorodumova E.A.
Adherence to therapy in patients with gout
|
93-101 |
REVIEWS |
Nevzorova V.A., Bondareva Zh.V., Potapova E.S., Egorova D.V.
Issues of immunoprophylaxis in the practice of a general practitio
|
102-114 |
Vertkin A.L., Shamuilova M.M., Knorring G.Yu.
Herbal medicinal products in treatment of respiratory infections
|
115-120 |
Alieva A.M., Pinchuk T.V., Batov M.A., Voronkova K.V., Valiev R.K., Shnakhova L.M., Kalova M.R., Rakhaev A.M., Arakelyan R.A., Nikitin I.G.
Sindecan-1 and cardiovascular diseases
|
121-128 |
GUIDELINES FOR PRACTITIONERS |
Larina V.N., Karpenko D.G.
Possibilities of combined antiplatelet and anticoagulant therapy in older patients without atrial fibrillation
|
129-137 |
Druk I.V., Pomorgailo E.G., Martirosyan K.A., Petrosyan V.Yu., Trofimova N.N.
Tumor of the genital cord
|
138-142 |
LECTURE |
Babak S.L., Budnevsky A.V., Buzunov R.V.
Modern strategy of diagnosis and therapy of patients with obstructive sleep apnea
|
144-150 |
ACTUAL ISSUES OF PHARMACOTHERAPY |
Lyamina N.P.
Modern strategy of anti-ischemic therapy for patients with chronic coronary syndromes
|
151-157 |
Shishkova V.N., Kotova M.B., Kapustina L.A., Imamgayazova K.E.
Issues of pathogenesis of cognitive and psychoemotional disorders in patients with cardiovascular and metabolic diseases
|
158-163 |
Katunina E.A.
Limbic-predominant age-related TDP-43 encephalopathy: new nosological form of dementia
|
164-171 |
Frolova Yu.V., Golanova N.M., Listradenkova D.G., Amon E.P., Malinnikova E.Yu.
Results of observational post-registration study of the efficacy and safety of Trekrezan® medicine use in adult patients with acute respiratory viral infection
|
172-181 |
Activities of RNMOT |
Digest events in OCTOBER 2021
|
182-186 |
WE REMEMBER |
Borodulin V.I., Stochik A.A.
On the problem of institutionalization of therapeutic disciplines: Academician of the USSR Academy of Medical Sciences A.I. Nesterov as the founder of Soviet rheumatology
|
187-192 |